Do analysts rate BHC or TLRY?

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 142.26%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Companies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor BHC or TLRY?

In the previous week, Bausch Health Companies had 4 more articles in the media than Tilray Brands. MarketBeat recorded 6 mentions for Bausch Health Companies and 2 mentions for Tilray Brands. Bausch Health Companies' average media sentiment score of 2.00 beat Tilray Brands' score of -0.02 indicating that Bausch Health Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Companies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tilray Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AUP or TLRY?

Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 142.26%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer CARA or TLRY?

Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 142.26%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, CARA or TLRY?

Cara Operations has higher earnings, but lower revenue than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cara Operations N/A N/A N/A N/A N/A Tilray Brands C$858.28M 0.79 -C$183.24M -C$14.63 N/A

Which has stronger earnings and valuation, TLRY or CRON?

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$858.28M 0.79 -C$183.24M -C$14.63 N/A Cronos Group C$159.54M 9.30 -C$32.78M N/A N/A

Tilray Brands (TLRY) Competitors

C$5.49 -0.11 (-1.96%)

As of 07/24/2026 04:00 PM Eastern

Compare

TLRY vs. BHC, AUP, SLS, CARA, and CRON

Should you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Solaris Resources (SLS), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Bausch Health Companies?

Bausch Health Companies (TSE:BHC) and Tilray Brands (TSE:TLRY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk and analyst recommendations.

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch Health Companies	C$10.53B	0.22	-C$125.65M	-C$3.24	N/A
Tilray Brands	C$858.28M	0.79	-C$183.24M	-C$14.63	N/A

Bausch Health Companies has a beta of 0.973491, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.0845, indicating that its stock price is 208% more volatile than the broader market.

Tilray Brands has a consensus price target of C$13.30, suggesting a potential upside of 142.26%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch Health Companies	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bausch Health Companies	-13.54%	120.43%	4.16%
Tilray Brands	-158.75%	-88.06%	-1.41%

In the previous week, Bausch Health Companies had 4 more articles in the media than Tilray Brands. MarketBeat recorded 6 mentions for Bausch Health Companies and 2 mentions for Tilray Brands. Bausch Health Companies' average media sentiment score of 2.00 beat Tilray Brands' score of -0.02 indicating that Bausch Health Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bausch Health Companies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Tilray Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

10.7% of Bausch Health Companies shares are held by institutional investors. Comparatively, 4.2% of Tilray Brands shares are held by institutional investors. 11.3% of Bausch Health Companies shares are held by insiders. Comparatively, 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Bausch Health Companies beats Tilray Brands on 10 of the 14 factors compared between the two stocks.

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals (TSE:AUP) and Tilray Brands (TSE:TLRY) are both pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A
Tilray Brands	C$858.28M	0.79	-C$183.24M	-C$14.63	N/A

In the previous week, Tilray Brands had 2 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 beat Tilray Brands' score of -0.02 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Aurinia Pharmaceuticals	Neutral
Tilray Brands	Neutral

Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 142.26%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts plainly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

4.2% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aurinia Pharmaceuticals	N/A	N/A	N/A
Tilray Brands	-158.75%	-88.06%	-1.41%

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 8 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Solaris Resources?

Tilray Brands (TSE:TLRY) and Solaris Resources (TSE:SLS) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

Tilray Brands has a beta of 3.0845, meaning that its share price is 208% more volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.777576, meaning that its share price is 78% more volatile than the broader market.

4.2% of Tilray Brands shares are held by institutional investors. Comparatively, 16.5% of Solaris Resources shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Comparatively, 40.6% of Solaris Resources shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 60.97% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Solaris Resources	N/A	60.97%	-51.67%

Solaris Resources has lower revenue, but higher earnings than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.79	-C$183.24M	-C$14.63	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

In the previous week, Tilray Brands had 2 more articles in the media than Solaris Resources. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Solaris Resources. Solaris Resources' average media sentiment score of 0.00 beat Tilray Brands' score of -0.02 indicating that Solaris Resources is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Neutral
Solaris Resources	Neutral

Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 142.26%. Solaris Resources has a consensus target price of C$19.50, suggesting a potential upside of 80.72%. Given Tilray Brands' higher probable upside, equities analysts plainly believe Tilray Brands is more favorable than Solaris Resources.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Solaris Resources beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Cara Operations (TSE:CARA) and Tilray Brands (TSE:TLRY) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

Cara Operations has higher earnings, but lower revenue than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cara Operations	N/A	N/A	N/A	N/A	N/A
Tilray Brands	C$858.28M	0.79	-C$183.24M	-C$14.63	N/A

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cara Operations	N/A	N/A	N/A
Tilray Brands	-158.75%	-88.06%	-1.41%

Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 142.26%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tilray Brands had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cara Operations. Cara Operations' average media sentiment score of 0.00 beat Tilray Brands' score of -0.02 indicating that Cara Operations is being referred to more favorably in the media.

Company	Overall Sentiment
Cara Operations	Neutral
Tilray Brands	Neutral

4.2% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Tilray Brands beats Cara Operations on 6 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (TSE:TLRY) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Cronos Group has lower revenue, but higher earnings than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.79	-C$183.24M	-C$14.63	N/A
Cronos Group	C$159.54M	9.30	-C$32.78M	N/A	N/A

Cronos Group has a net margin of -1.29% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.19% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Cronos Group	-1.29%	-0.19%	-3.73%

Tilray Brands has a beta of 3.0845, indicating that its stock price is 208% more volatile than the broader market. Comparatively, Cronos Group has a beta of 1.126226, indicating that its stock price is 13% more volatile than the broader market.

In the previous week, Tilray Brands had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.00 beat Tilray Brands' score of -0.02 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Neutral
Cronos Group	Neutral

Tilray Brands currently has a consensus price target of C$13.30, indicating a potential upside of 142.26%. Cronos Group has a consensus price target of C$4.75, indicating a potential upside of 19.65%. Given Tilray Brands' higher probable upside, equities research analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

4.2% of Tilray Brands shares are owned by institutional investors. Comparatively, 4.3% of Cronos Group shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Comparatively, 46.4% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Cronos Group beats Tilray Brands on 9 of the 15 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$677.78M	C$2.25B	C$6.88B	C$12.48B
Dividend Yield	N/A	2.81%	2.67%	6.19%
P/E Ratio	-0.38	5.00	27.00	36.95
Price / Sales	0.79	1,642.24	491.80	9.44
Price / Cash	5.95	10.18	50.54	82.29
Price / Book	0.41	9.91	10.28	4.39
Net Income	-C$183.24M	C$20.27B	C$3.60B	C$299.09M
7 Day Performance	-9.41%	-0.87%	-1.25%	0.61%
1 Month Performance	-13.41%	0.08%	-0.35%	1.06%
1 Year Performance	-41.60%	7.16%	18.41%	30.89%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	1.3425 of 5 stars	C$5.49 -2.0%	C$13.30 +142.3%	-43.4%	C$677.78M	C$858.28M	N/A	2,650
BHC Bausch Health Companies	0.895 of 5 stars	C$6.85 +2.4%	N/A	-32.4%	C$2.50B	C$10.53B	N/A	19,900	News Coverage Analyst Upgrade Analyst Revision
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
SLS Solaris Resources	1.419 of 5 stars	C$10.51 -4.5%	C$19.50 +85.5%	+56.6%	C$1.84B	N/A	N/A	10
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Summary

How does Tilray Brands compare to Solaris Resources?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Which has higher valuation & earnings, BHC or TLRY?

Which has more risk & volatility, BHC or TLRY?

Do analysts rate BHC or TLRY?

Is BHC or TLRY more profitable?

Does the media favor BHC or TLRY?

Do insiders and institutionals hold more shares of BHC or TLRY?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Which has preferable valuation & earnings, AUP or TLRY?

Does the media favor AUP or TLRY?

Do analysts recommend AUP or TLRY?

Do insiders & institutionals have more ownership in AUP or TLRY?

Is AUP or TLRY more profitable?

Summary

How does Tilray Brands compare to Solaris Resources?

Which has more risk & volatility, TLRY or SLS?

Do insiders and institutionals believe in TLRY or SLS?

Is TLRY or SLS more profitable?

Which has preferable valuation & earnings, TLRY or SLS?

Does the media prefer TLRY or SLS?

Do analysts recommend TLRY or SLS?

Summary

How does Tilray Brands compare to Cara Operations?

Which has better earnings & valuation, CARA or TLRY?

Is CARA or TLRY more profitable?

Do analysts prefer CARA or TLRY?

Does the media prefer CARA or TLRY?

Do institutionals & insiders believe in CARA or TLRY?

Summary

How does Tilray Brands compare to Cronos Group?

Which has stronger earnings and valuation, TLRY or CRON?

Is TLRY or CRON more profitable?

Which has more risk & volatility, TLRY or CRON?

Does the media prefer TLRY or CRON?

Do analysts rate TLRY or CRON?

Do insiders & institutionals have more ownership in TLRY or CRON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools